AESR, 2020-06-08, ANFIELD US EQUITY SECTOR ROT. AEY, 2020-06-08, ADDVANTAGE CZA, 2020-06-08, INVESCO ZACKS MID-CAP ETF. CZNC, 2020-06-08 SRRA, 2020-06-08, SIERRA ONCOLOGY INC. SRRK, 2020-06-08 SRRA, Sierra Oncology, Inc, Stock, NASDAQ, 16.07.2015, 11.01.2017 CVY, Zacks Multi-Asset Income Invesco ETF, ETF, AMEX, 21.09.2006, 02.01.2009. MHPCB ,"MHPC Series B Preferred Stock ",VIAF ,Direct Trades Only ALT. to All Clients CZOVX ,"ZACKS ALL-CAP CORE A CLASS A ",NSCC ,Requires ,Open to All Clients SRRA ,"SIERRA ONCOLOGY INC NEW ",NASD ,Open to All Zacks Investment Research is a leading provider of independent investment research with a proven track record of outperforming the market. The content for this 24 Jul 2017 operates electronic markets for the trading of listed equity securities in the United States (U.S.) KraneShares Zacks New China ETF. KGC.
SRRA - Sierra Oncology Stock Price - Barchart.com Sierra Oncology (SRRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings. SRRA : 14.01 (+0.94%) Sierra Oncology to Hold Year End 2019 & 2020 Outlook Analyst & Investor Call PR Newswire - Wed Feb 26, 6:00AM CST Sierra Oncology (NASDAQ:SRRA) Lowered to Hold at Zacks ... Sierra Oncology (NASDAQ:SRRA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Sierra Oncology, Inc. is a clinical-stage drug development company. It develops and markets drugs for the treatment of cancer. The product pipeline consists of SRA737 and […]
SHIP Seanergy Maritime Holdings Corp. — Stock Price and ... Seanergy Maritime Holdings Corp. SHIP 0.22 0.01 (5.72%). NASDAQ Updated Jun 9, 2020 8:05 AM Isoray Inc Stock Quote: ISR Stock News, Quotes, Analysis ... ISR, Isoray Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines SRRA - Ownership Information for SIERRA ONCOLOGY, INC ... View institutional stock ownership, mutual fund ownership, and top individual ownership of SIERRA ONCOLOGY, INC. (SRRA). msn back to msn home money. powered by Invesco Zacks Micro Cap ETF Sierra Oncology Inc (NASDAQ:SRRA) Given $74.00 Consensus ...
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus SRRA: Sierra Oncology Inc Detailed Estimate. Get the latest Detailed Estimate from Zacks Investment Research. SRRA: Sierra Oncology Inc - Interactive Chart Chart. Get the latest Interactive Chart for Sierra Oncology Inc from Zacks Investment Research Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. SRRA stock was acquired by a variety of institutional investors in the last quarter, including Vivo Capital LLC, Orbimed Advisors LLC, Abingworth LLP, and VR Adviser LLC. Company insiders that have bought Sierra Oncology stock in the last two years include Andrew R Allen, and Barbara Klencke. SRRA | Complete Sierra Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Zacks Investment Research upgraded shares of Sierra Oncology (NASDAQ:SRRA) from a hold rating to a buy rating in a report issued on Saturday, Zacks.com reports. The firm currently has $14.00
A reverse stock splits list, with links to full split history. SRRA Split History, 1 for 40, 01/23/2020 Direxion Zacks MLP High Income Index Shares (ZMLP).